Calls
2
u/OkEffective8588
Reddit r/stocks
Win Rate
50.0%
return
+11.7%
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jun 30
$48.49
-10.6%
Author argues NVO is a cheap stock for a short-term buy despite not being the weight-loss market leader, citing a P/E of about 11.5-12.6x below its 5-year average and billions in free cash flow. The author sees product similarity to LLY, with oral Wegovy showing slightly better side-effect results, though NVO's projected sales look less good than LLY's. Main stated risks are the expensive and risky clinical-trial setting and dependence on reducing side effects and expanding into different markets.
GLP-1 / Obesity
Long
Jun 24
$370.52
+34.0%
The author argues MSFT is a good buy after falling $130 from its October 2025 peak, trading at a PE of ~22 and forward PE of ~19. He contends Microsoft produces more 'useful' products than Meta, is less likely to be hit by regulation such as teen social media bans, and could see great upside. He holds a small position of 5 shares and is considering loading up, acknowledging the analysis is not deep.
Hyperscalers
Showing 2 of 2 calls · sorted by mentions
Choose a mentions count to open ticker posts.
u/OkEffective8588 has 2 trade ideas tracked on Buzzberg across 2 tickers since June 2026. Most covered: MSFT, NVO.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
